Ryan Specialty is the IBD Stock Of The Day as it trades near a buy point, finding key support. As with many of its insurance industry peers, Ryan Specialty is showing relative strength amid a market correction. But, it's still a market correction.
The wholesale broker and underwriter provides services to insurance brokers, agents and carriers. Ryan Specialty offers property, casualty, workers' compensation and transportation insurance, along with personal lines including homeowners and flood coverage. It's expanded through strategic acquisitions and organic growth.
Stock Of The Day: Ryan Specialty Earnings
Ryan Specialty earnings rose 29% in the fourth quarter, edging up from Q3's 28%. Revenue climbed 25% to $663.5 million, with growth picking up for a second straight quarter.
For 2025, analysts see Ryan earnings climbing 19%.
Shares Quickly Finding Support
Ryan Specialty shares rose 1.6% to 69.28 in Wednesday's stock market trading, closing above its 21-day moving average after finding support intraday at the 50-day line. RYAN stock has a 71.33 buy point from a cup-with-handle base.
The relative strength line for Ryan has been running up for most of 2025, but is not yet at consolidation or 52-week highs. The RS line, the blue line in the chart provided, tracks a stock's performance vs. the S&P 500 index.
Ryan Specialty has an average true range of 2.8%, relatively modest. In the volatile market correction, investors should look for stocks with 21-day ATR of less than 3%.
Even though RYAN stock is showing relative strength and is near a buy point, investors should mostly be building watchlists for the next market uptrend vs. making significant new buys.
The stock boasts a perfect Composite Rating of 99. IBD's Composite Rating combines various technical and fundamental metrics into one easy-to-read score. Further, Ryan bears a near-perfect 97 EPS Rating.
Please follow Ed Carson on Threads at @edcarson1971 and X/Twitter at @IBD_ECarson for stock market updates and more.
